INO has seen major gains due to virus outbreak

Inovio Pharmaceuticals has skyrocketed amid reports it may be developing a vaccine for the Coronavirus.

There's no patterns that can really be drawn on this chart, it's so vertical. The RSI says conditions are overbought, as to be expected, but the rally can easily continue after some profit-taking. Buyers still outweigh sellers in terms of volume.